πŸ‡ΊπŸ‡Έ FDA
Patent

US 10100012

Compounds as anti-tubercular agents

granted A61KA61K31/445A61K45/06

Quick answer

US patent 10100012 (Compounds as anti-tubercular agents) held by DRUG DISCOVERY RESEARCH CENTRE expires Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
DRUG DISCOVERY RESEARCH CENTRE
Grant date
Tue Oct 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 11 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/445, A61K45/06, A61P, A61P31/06